Immunohistochemistry Breast Cancer Panel 2 Test
Comprehensive Breast Cancer Biomarker Analysis
The Immunohistochemistry Breast Cancer Panel 2 Test represents a cutting-edge diagnostic approach in breast cancer management. This specialized panel utilizes advanced immunohistochemistry techniques to detect and quantify specific protein markers in breast tissue samples, providing critical information that guides personalized treatment decisions and predicts disease outcomes.
What This Test Measures and Detects
Our comprehensive panel evaluates three essential biomarkers that play crucial roles in breast cancer diagnosis and treatment planning:
- Estrogen Receptor (ER): Determines if breast cancer cells have estrogen receptors, indicating whether the cancer is likely to respond to hormone therapy
- Progesterone Receptor (PR): Assesses progesterone receptor status, providing additional information about hormone responsiveness
- Cathepsin D: Evaluates this lysosomal protease that has been associated with tumor progression and metastasis in breast cancer
The test includes expert pathologist review to confirm the presence of malignant cells and ensure accurate interpretation of biomarker expression patterns.
Who Should Consider This Test
This advanced diagnostic panel is recommended for individuals who:
- Have been diagnosed with breast cancer through biopsy
- Require comprehensive biomarker analysis for treatment planning
- Need determination of hormone receptor status for targeted therapy decisions
- Are undergoing evaluation for metastatic breast cancer
- Require prognostic information to guide long-term management strategies
Key Benefits of the Immunohistochemistry Breast Cancer Panel 2
Choosing our comprehensive breast cancer panel offers numerous advantages:
- Personalized Treatment Planning: Results guide the selection of targeted therapies, including hormone treatments for ER/PR positive cancers
- Prognostic Information: Biomarker status provides valuable insights into disease progression and potential outcomes
- Comprehensive Analysis: Multiple biomarkers assessed simultaneously for efficient diagnostic evaluation
- Expert Interpretation: Board-certified pathologists review all results to ensure accuracy and clinical relevance
- Timely Results: Rapid turnaround times to support prompt treatment decisions
Understanding Your Test Results
Your comprehensive test report will include detailed information about each biomarker:
- ER Status: Positive results indicate potential responsiveness to hormone therapy, while negative results may suggest alternative treatment approaches
- PR Status: Combined with ER status, provides comprehensive hormone receptor profile
- Cathepsin D Expression: Elevated levels may indicate more aggressive disease characteristics
- Pathologist Interpretation: Expert analysis of biomarker patterns and clinical significance
Your healthcare provider will discuss the specific implications of your results and develop a personalized treatment plan based on the comprehensive biomarker profile.
Test Pricing and Availability
| Test Component | Price |
|---|---|
| Immunohistochemistry Breast Cancer Panel 2 Test | $212 USD |
| Discount Price | $150 USD |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Take the Next Step in Your Breast Cancer Journey
Don’t wait to get the comprehensive diagnostic information you need for informed treatment decisions. Our Immunohistochemistry Breast Cancer Panel 2 Test provides the critical biomarker data that can make a significant difference in your treatment outcomes.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our oncology specialists about whether this comprehensive panel is right for your situation.
Our dedicated team is available to answer your questions, explain the testing process, and help you understand how these results can guide your personalized breast cancer treatment plan. Take control of your health journey with the advanced diagnostic insights our panel provides.
